In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

INTRODUCTION: Treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the maintenance of TFR, and immunologic surveillance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, María Belén, Vasconcelos Cordoba, Bianca, Pavlovsky, Carolina, Moiraghi, Beatriz, Varela, Ana, Custidiano, Rosario, Fernandez, Isolda, Freitas, María Josefina, Ventriglia, María Verónica, Bendek, Georgina, Mariano, Romina, Mela Osorio, María José, Pavlovsky, Miguel Arturo, García de Labanca, Ana, Foncuberta, Cecilia, Giere, Isabel, Vera, Masiel, Juni, Mariana, Mordoh, José, Sanchez Avalos, Julio Cesar, Levy, Estrella Mariel, Bianchini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561287/
https://www.ncbi.nlm.nih.gov/pubmed/37818372
http://dx.doi.org/10.3389/fimmu.2023.1241600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561287/
https://www.ncbi.nlm.nih.gov/pubmed/37818372
http://dx.doi.org/10.3389/fimmu.2023.1241600

Ejemplares similares